Home/Filings/4/0001209191-21-050515
4//SEC Filing

Wirick Angela L 4

Accession 0001209191-21-050515

CIK 0001323885other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 8:06 AM ET

Size

6.8 KB

Accession

0001209191-21-050515

Insider Transaction Report

Form 4
Period: 2021-08-06
Wirick Angela L
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2021-08-06$80.21/sh5,939$476,36777,941 total
  • Tax Payment

    Common Stock

    2021-08-06$83.75/sh5,191$434,74672,750 total
Footnotes (3)
  • [F1]These shares were sold pursuant to a 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $78.52 to $81.50 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001819885

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 8:06 AM ET
Size
6.8 KB